Dr. Ceradini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
222 E 41st St
Fl 6
New York, NY 10017Phone+1 212-263-3030
Summary
- Dr. Daniel Ceradini is a plastic surgeon in New York, NY and is affiliated with multiple hospitals in the area, including VA NY Harbor Healthcare System, Manhattan Campus and NYU Langone Hospitals. He received his medical degree from NYU School of Medicine and has been in practice 21 years. He specializes in aesthetic/cosmetic plastic surgery, breast reconstruction, and plastic & reconstructive microsurgery and is experienced in facial plastic and reconstructive surgery, cosmetic surgery, breast reconstruction, breast surgery, and plastic and reconstructive microsurgery.
Education & Training
- NYU Grossman School of MedicineResidency, Plastic Surgery - Integrated, 2006 - 2009
- NYU Grossman School of MedicineResidency, Surgery, 2005 - 2006
- NYU Grossman School of MedicineResidency, Plastic Surgery - Integrated, 2004 - 2005
- NYU Grossman School of MedicineResidency, Surgery, 2000 - 2004
- New York University School of MedicineClass of 2000
- The Rockefeller UniversityPost-baccalaureate, Medical Research, 1996 - 1997
- Stony Brook UniversityBaccalaureate, Medical Research, 1996
- State University of New York at Stony BrookB.S., Biochemistry, Magna Cum Laude, 1991 - 1995
Certifications & Licensure
- NY State Medical License 2005 - 2025
- American Board of Plastic Surgery Plastic Surgery
Awards, Honors, & Recognition
- Academic Scholar Award American Association of Plastic Surgeons, 2010
- James Barrett Brown Award, Co-Author 2009
- Second Place Research Award (Mentor) New York Regional Society of Plastic Surgery Meeting, 20132014
- Join now to see all
Clinical Trials
- Craniomaxillofacial Allotransplantation Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- 2346 citationsHomozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 InfectionRong Liu, William A. Paxton, Sunny Choe, Daniel Ceradini, Scott R. Martin
Cell. 1996-08-09 - 2065 citationsProgenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1Daniel J. Ceradini, Anita R Kulkarni, Matthew J. Callaghan, Oren M. Tepper, Nicholas Bastidas
Nature Medicine. 2004-07-04 - 50 citationsDysregulation of Nrf2/Keap1 Redox Pathway in Diabetes Affects Multipotency of Stromal CellsPiul S. Rabbani, Marc A. Soares, Sophia Hameedi, Rohini L. Kadle, Adnan Mubasher
Diabetes. 2019-01-01
Journal Articles
- Dysregulation of Nrf2/Keap1 Redox Pathway in Diabetes Affects Multipotency of Stromal CellsMarc A Soares, Sophia G Hameedi, Daniel J Ceradini, Rohini L Kadle, Adnan Mubasher, Diabetes Care
- Jaw in a day: total maxillofacial reconstruction using digital technologyLevine JP, Bae JS, Soares M, Brecht LE, Saadeh PB, Ceradini DJ, Hirsch DL, Plast Reconstr Surg, 6/1/2013
- Microsurgical Craniomaxillofacial Reconstruction for Giant Ameloblastoma: A Ten-Year PerspectiveBroer PN, Tanna N, Franco PD, Thanik VD, Garfein ES, Saadeh PB, Ceradini DJ, Hirsch DL, Levine JP, J Reconstr Microsurg, 3/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Pharmacologic Inhibition of Phosphodiesterase 5 as a Strategy to Improve Outcomes in Microvascular Surgery.Marc Soares, MD, Piul Rabbani, PhD, April Duckworth, MD, Nick Rao, MD, Jessica Chang, BA, Pierre B. Saadeh, MD, Karan Mehta, BA, Amanda Kua, BA, Daniel J Ceradini, MD, Plastic Surgery Research Council, 1/1/2014
- An Engineered Lipoproteoplex Presents Robust Delivery Mechanism For Topical Gene Therapy.Piul S. Rabbani, PhD, Joseph A. Frezzo, MS, Maria Ham, MD, April Duckworth, MD, Muhammad Hyder Junejo, BS, Nakul Talathi, Camilo Doig-Acuna, BS, Haresh More, MTech, Ke..., Plastic Surgery Research Council, 1/1/2014
- Primed Mesenchymal Stem Cells Prevent Endothelial Activation and Improve Allograft Perfusion Following Transplantation.Jessica B. Chang, BS, Marc A. Soares, MD, Jonathan P. Massie, BS, April Duckworth, MD, Nakul Rao, MD, Camille Kim, BS, Karan Mehta, BS, Amanda Hua, BS, Piul Rabbani, P..., Plastic Surgery Research Council, 1/1/2014
- Join now to see all
Lectures
- "Inside-out tissue engineering: using free flaps as vascularized scaffolds for organ level tissue engineering."New York - 1/1/2009
- "Therapeutic blockade of reactive oxygen species prevents diabetic vascular complications."New York - 1/1/2007
- "Novel Approach to Improving Ischemic Complications in Diabetes."New York - 1/1/2006
Press Mentions
- The World’s First Whole-Eye & Partial-Face Transplant Recipient Achieves Remarkable Recovery, with Viable Eye One Year After Landmark SurgerySeptember 9th, 2024
- Experimental Stem Cell Therapy Speeds up Wound Healing in DiabetesJanuary 3rd, 2019
- How 3-D Printers Gave Zeesy Stern a New JawJanuary 10th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: